Some public health issues in the current state of genetic testing for breast cancer in Australia

Australian and New Zealand Journal of Public Health

Volumn 20, Issue 5, 1996, Pages 467-472

  Hopper, John L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN;

EID: 0029905033     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1996.tb01623.x     Document Type: Article

References (28)

1. Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol 1992; 136: 1138-47.
2. Hopper JL. The genetic epidemiology of breast cancer. Today's Life Sci 1995; 7: 22-6.
3. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 69: 820-3.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, et al. A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
5. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
6. Easton DF, Bishop DT, Ford D, Crockford GP, et al. and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701.
7. Ford D, Easton DF, Bishop ST, Narod SA, Goldgar DE, and the Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-5.
8. Wooster R, Neuhausen S, MangionJ, et al. Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome. 13q 12-13. Science 1994; 265: 2088-90.
9. Easton DF, Narod SA, Ford D et al. The genetic epidemiology of BRCA1. Lancet 1994; 344: 761.
10. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57: 1457-62.
11. Struewing JP, Abeliovich D, Peretz T, Avishai N, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995; 11: 198-200.
12. Hopper JL, Giles GG, McCredie MRE, Boyle P. Background, rationale and protocol for a case-control-family study of breast cancer. Breast 1994; 3: 79-86.
13. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-8.
14. Easton D, Ford D, Peto J. Inherited susceptibility to breast cancer. Cancer Surv 1993; 18: 95-113.
15. Savitsky K, Bar-Shira A, Gilad S, Rotman G, et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-53.
16. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316: 1289-94.
17. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831-6.
18. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993; 329: 517-23.
19. Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, et al. Family history, age, and risk of breast cancer: prospective data from the Nurses' Health Study. J Amer Med Assoc 1993; 270: 338-43.
20. Sellers TA, Potter JD, Rich SS, et al. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 1994; 86; 1860-5.
21. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-8.
22. Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84: 1114-17
23. McCredie M, Hopper JL, Cawson JN. Risk factors and preventive strategies for breast cancer. Med J Aust 1995; 163: 435-40.
24. Claus EB, Risch N, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131: 961-72.
25. Gail MH, Brinton LA, Byer DP, Corle DK, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879-86.
26. Gayther SA, Warren W, Mazoyer S, Russell PA, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation, Nature Genet 1995; 11: 428-33.
27. Colditz GA, Rosner BA, Speizer FE. Risk factors for breast cancer according to family history of breast cancer. J Natl Cancer Inst 1996; 88: 365-71.
28. Sellers TA, Kushi LH, Potter JD, Kaye SA, et al. Effect of family history, body-fat distribution, and reproductive risk factors on the risk of post-menopausal breast cancer [published erratum appears in N Engl J Med 1992; 327: 1612] [see comment citation in Medline]. N Engl J Med 1992; 236: 1323-9.